"Barnsty SLA have the patented use of Ropren to treat the liver and have advanced trials over the past few years over their use to treat alzheimers and in normalising cholestorol. So I do not believe there is a risk we'll lose out on these two markets i.e. I believe once the final trials are complete SLA will move to get patents over those treatment areas too."
Found this
Solagran Ltd Granted Patents For Treatment Of Alzheimers And Alcoholism Australian Biotech Solagran Limited (ASX: SLA) announced it had been awarded the world's first patents protecting the use of plant polyprenols in the treatment of conditions involving physical, psychological and neurological degeneration. Two patents were awarded.
link http://www.alcoholismnewz.com/
SLA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)